MedTrace Logo

a 3.0T Magnetic Resonance Imaging Study

NCT01346904 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2011-05-03

No results posted yet for this study

Summary

Glaucomatous damage not only occurred to retinal ganglion cells in the eyes, but went across optic nerves, visual chiasm, lateral geniculate nucleus (LGN) and finally the visual cortex; the neural degenerations could be identified through the whole visual tract, which suggests the central nerve system may play a vital role in the progression of glaucoma. The investigators used MRI to investigate changes of visual pathway in vivo.

Conditions

  • Primary Open Angle Glaucoma

Sponsors & Collaborators

  • Sun Yat-sen University

    collaborator OTHER

  • Huazhong University of Science and Technology

    lead OTHER

Principal Investigators

  • HONG ZHANG, PHD · Tongji Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2012-12-31
Completion
2012-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01346904 on ClinicalTrials.gov